Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Solitary Pulmonary Nodule 1NSCLC 1Lung Neoplasms 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 128Carboplatin 126Pemetrexed 106Cisplatin 79Paclitaxel 60osimertinib 54Nivolumab 53Docetaxel 52durvalumab 48Specimen Handling 40Magnetic Resonance Spectroscopy 36Gemcitabine 36Radiosurgery 29atezolizumab 27130-nm albumin-bound paclitaxel 27Cetuximab 26Radiotherapy 23Ipilimumab 22Drug Therapy 22cemiplimab 20Bevacizumab 20amivantamab 18Taxes 16Ramucirumab 13tislelizumab 12alectinib 12Radiation 12Biopsy 12lazertinib 11Oxaliplatin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma, Non-Small-Cell Lung × Anterior Temporal Lobectomy × 90 days × Clear all
NCT03237377 2026-05-27

Neoadjuvant Immunoradiation for Resectable Non-Small Cell Lung Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
9 enrolled 14 charts
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07537556 2026-04-17

RATS_RYC

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Active not recruiting
150 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Solitary Pulmonary Nodule, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡